MW 463.39 g/mol.
Negative control for clathrin inhibitor Pitstop® 2-100 (ab144650). Structurally related to Pitstop® 2-100 but unable to associate with the clathrin terminal domain. No effect on clathrin-mediated endocytosis (CME) of transferrin or major histocompatibility complex 1 (MHCI) uptake.
MW 463.39 g/mol.
Negative control for clathrin inhibitor Pitstop® 2-100 (ab144650). Structurally related to Pitstop® 2-100 but unable to associate with the clathrin terminal domain. No effect on clathrin-mediated endocytosis (CME) of transferrin or major histocompatibility complex 1 (MHCI) uptake.
Soluble in DMSO.
Negative control for clathrin inhibitor Pitstop® 2-100 (ab144650). Structurally related to Pitstop® 2-100 but unable to associate with the clathrin terminal domain. No effect on clathrin-mediated endocytosis (CME) of transferrin or major histocompatibility complex 1 (MHCI) uptake.
Sold under exclusive licence from Children's Medical Research Institute and Newcastle Innovation Ltd. Pitstop® is a trademark of Freie Universitat Berlin, Newcastle Innovation Ltd. and Children's Medical Research Institute.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab144658, Pitstop® 2-100 - negative control
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com